These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 12235214)

  • 1. Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo.
    den Haan JM; Bevan MJ
    J Exp Med; 2002 Sep; 196(6):817-27. PubMed ID: 12235214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
    Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
    J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel role of complement factor C1q in augmenting the presentation of antigen captured in immune complexes to CD8+ T lymphocytes.
    van Montfoort N; de Jong JM; Schuurhuis DH; van der Voort EI; Camps MG; Huizinga TW; van Kooten C; Daha MR; Verbeek JS; Ossendorp F; Toes RE
    J Immunol; 2007 Jun; 178(12):7581-6. PubMed ID: 17548593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FcRγ-chain ITAM signaling is critically required for cross-presentation of soluble antibody-antigen complexes by dendritic cells.
    Boross P; van Montfoort N; Stapels DA; van der Poel CE; Bertens C; Meeldijk J; Jansen JH; Verbeek JS; Ossendorp F; Wubbolts R; Leusen JH
    J Immunol; 2014 Dec; 193(11):5506-14. PubMed ID: 25355925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
    Ho NI; Camps MGM; de Haas EFE; Ossendorp F
    Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.
    den Haan JM; Lehar SM; Bevan MJ
    J Exp Med; 2000 Dec; 192(12):1685-96. PubMed ID: 11120766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine.
    Schuurhuis DH; van Montfoort N; Ioan-Facsinay A; Jiawan R; Camps M; Nouta J; Melief CJ; Verbeek JS; Ossendorp F
    J Immunol; 2006 Apr; 176(8):4573-80. PubMed ID: 16585547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses.
    Desai DD; Harbers SO; Flores M; Colonna L; Downie MP; Bergtold A; Jung S; Clynes R
    J Immunol; 2007 May; 178(10):6217-26. PubMed ID: 17475849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.
    Adams EW; Ratner DM; Seeberger PH; Hacohen N
    Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
    Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
    Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.
    Schmidt ST; Khadke S; Korsholm KS; Perrie Y; Rades T; Andersen P; Foged C; Christensen D
    J Control Release; 2016 Oct; 239():107-17. PubMed ID: 27574990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complex-mediated antigen presentation induces tumor immunity.
    Rafiq K; Bergtold A; Clynes R
    J Clin Invest; 2002 Jul; 110(1):71-9. PubMed ID: 12093890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization.
    Regnault A; Lankar D; Lacabanne V; Rodriguez A; Théry C; Rescigno M; Saito T; Verbeek S; Bonnerot C; Ricciardi-Castagnoli P; Amigorena S
    J Exp Med; 1999 Jan; 189(2):371-80. PubMed ID: 9892619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells.
    Utsugi-Kobukai S; Fujimaki H; Hotta C; Nakazawa M; Minami M
    Immunol Lett; 2003 Oct; 89(2-3):125-31. PubMed ID: 14556969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active dissemination of cellular antigens by DCs facilitates CD8
    Gurevich I; Feferman T; Milo I; Tal O; Golani O; Drexler I; Shakhar G
    Eur J Immunol; 2017 Oct; 47(10):1802-1818. PubMed ID: 28872666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.